ASHLEY CARDENAS: Open Payments
NPI 1619444163 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,677 in 80 payments from 20 companies in 2025. Trend: 2023 $1,717 · 2024 $1,905 · 2025 $1,677
Food & beverage: $1,563Education: $114
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $300 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $194 |
| Regeneron Healthcare Solutions, Inc. | 7 | $194 |
| Organon LLC | 4 | $165 |
| Novartis Pharmaceuticals Corporation | 7 | $157 |
| Lilly USA, LLC | 4 | $99 |
| Janssen Biotech, Inc. | 4 | $88 |
| Arcutis Biotherapeutics, Inc. | 3 | $61 |
| Journey Medical Corporation | 2 | $55 |
| GENZYME CORPORATION | 2 | $54 |
Products named: DUPIXENT, SKYRIZI, VTAMA, TALTZ, RINVOQ, TREMFYA, ILUMYA, COSENTYX.
Industry payments across TX — which companies pay providers there.
